Aims
Our aims ensure we are putting patients in the driving seat and enabling best care, whilst adapting to the ever growing evidence base.
Learning outcomes
By attending this event, attendees will be updated on the latest evidence in food allergy, including:
- Latest research in food allergy
- Management of legume allergy
- Impact of migration on allergies and allergy practice
- Allergies and food manufacture
- Adolescent food allergy
- Transition from paediatric to adult services
Who should attend
This study day is suitable for all health care professionals working with children and adults with food allergy, including:
- Allergists
- Paediatric Allergists
- Clinicians with special interest in allergy
- Nurses and Allied Health Professionals working in allergy
- Trainees
Latest agenda
How to book
Sponsors
Allergy solutions for life:
More than 500 million people worldwide have allergies. Many of them suffer in silence because the way ahead is too confusing.
By collecting information and the latest and most trusted solutions together in one place, we want to make allergy surprisingly simple to manage. With 100 years of experience, nobody knows allergy like us, and we continuously apply our scientific knowledge and expertise to help people take control of their allergy and their life.
We want to make a difference by offering solutions for everyone who is touched by allergy – through a comprehensive range of products, services and resources that offer a fast-track to a more balanced life.
Thermo Fisher Scientific is a global leader in allergy and autoimmunity diagnostics, providing you with accurate and clinically relevant testing solutions to aid in disease diagnosis and patient management. Our ImmunoCAP allergy solutions are considered the gold standard in in-vitro allergy diagnostics and provide results that help in optimizing your diagnosis. ImmunoCAP tests help laboratories provide relevant and science-based information that healthcare providers can use to develop evidence-based symptom-management plans.